𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The association of benign prostatic hyperplasia and cancer of the prostate

✍ Scribed by David G. Bostwick; William H. Cooner; Louis Denis; George W. Jones; Peter T. Scardino; Gerald P. Murphy

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
976 KB
Volume
70
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Polymorphisms of fibroblast growth facto
Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population
✍ Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Takamitsu Inoue; Teruaki Kumazawa; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 138 KB πŸ‘ 1 views

## Abstract Fibroblast growth factor receptor 4 (FGFR4) is a member of a family of transmembrane receptors with ligand‐induced tyrosine kinase activity. The Glycine (Gly) to Arginine (Arg) polymorphism at codon 388 (Gly388Arg), which encodes an amino acid in the transmembrane part of the FGFR4 gene

Family history of cancer and the risk of
Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia
✍ Eva Negri; Claudio Pelucchi; Renato Talamini; Maurizio Montella; Silvano Gallus; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 76 KB πŸ‘ 2 views

## Abstract We analysed the relation between family history of cancer in first‐degree relatives and risk of prostate cancer (PC) and benign prostatic hyperplasia (BPH) using data from a multicentric case‐control study conducted in Italy from 1991 to 2002 on 1,294 cases of incident, histologically c

Leptin in relation to prostate cancer an
Leptin in relation to prostate cancer and benign prostatic hyperplasia
✍ Pagona Lagiou; Lisa B. Signorello; Dimitrios Trichopoulos; Anastasia Tzonou; Ant πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 44 KB πŸ‘ 2 views

The aim of our study was to determine whether leptin, a hormone implicated in both energy-balance and reproductive function, is involved in the etiology of prostate cancer or benign prostatic hyperplasia (BPH). We compared the serum leptin levels of 43 cases of incident prostate cancer, 41 patients